Our Stories

Featured

Our Stories

Featured

Improving Oncology Patient Outcomes: The Future of Risk-Based Care

Research shows that Biologics by McKesson’s pioneering risk-based care program maximizes patients’ time on therapy, leading to better oncology patient outcomes.

Carcinoid Cancer Foundation Q&A

Patient Advocacy

The Carcinoid Cancer Foundation’s mission is to increase awareness and education among the general public and healthcare providers about neuroendocrine tumors (NETs), to support NET cancer patients and their loved ones, and to serve as patient advocates. There are at least 175,000 people living with NETs in the United States.

Aplastic Anemia/MDS International Foundation Q&A

Patient Advocacy

The Aplastic Anemia and MDS International Foundation (AAMDSIF) is the world’s leading nonprofit supporting people affected by bone marrow disorders. It helps patients in all stages of treatment, providing information, support services, and a caring community.

National Neutropenia Network Q&A

Patient Advocacy

The National Neutropenia Network supports those affected by neutropenia, a rare blood condition. It aims to promote awareness, education, and research, while providing a support system for patients with chronic neutropenia.

ACPMP Research Foundation Q&A

The ACPMP Research Foundation was founded in 2008. Its mission is to fund research to find a cure for appendix cancer, PMP and related peritoneal surface malignancies; and to fund and support educational programs for physicians, clinicians, patients, family members and caregivers.

No Stomach For Cancer Foundation Q&A

No Stomach For Cancer Foundation aims to advance awareness about stomach cancer; provide a support network for affected families; and encourage research efforts for early detection, screening and prevention of the disease.

SYNGAP1 Foundation Q&A

The SYNGAP1 Foundation was founded in 2014. Today, it is the leading non-profit patient advocacy group dedicated to improving the quality of life for patients and families affected by the rare SYNGAP1 gene mutation or a variant.

Spotlight

CAMCEVI® (leuprolide) 42mg injection emulsion, FDA Approved for Treatment of Advanced Prostate Cancer, Available Exclusively at Biologics by McKesson

CARY, N.C., June 19, 2024—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected by Accord BioPharma, Inc. as an exclusive specialty pharmacy provider for CAMCEVI (leuprolide) 42mg injection...

Employee Voices

Improving Oncology Patient Outcomes: The Future of Risk-Based Care

Ela Lourido, Vice President and General Manager, Specialty Pharmacy ServicesResearch shows that Biologics by McKesson’s pioneering risk-based care program maximizes patients’ time on therapy, leading to better oncology patient outcomes. Now, its partnership with Arine...

Carcinoid Cancer Foundation Q&A

What is the Carcinoid Cancer Foundation? The Carcinoid Cancer Foundation (CCF), created in 1968, is the oldest neuroendocrine cancer foundation in the United States, and to the best of our knowledge, in the entire world. The Foundation’s mission is threefold: to...

Aplastic Anemia/MDS International Foundation Q&A

What is the Aplastic Anemia and MDS International Foundation? The Aplastic Anemia and MDS International Foundation (AAMDSIF) is dedicated to assisting and supporting people who have bone marrow disorders, including aplastic anemia, myelodysplastic syndrome and...

Business Insights

Video Transcript: Risk-Based Care: Personalized care for better patient outcomes

Risk-Based Care: Personalized care for better patient outcomes Daniel Weaver, BSN, RN, Director, Clinical Innovation and Strategy, Biologics by McKesson: When patients are referred to Biologics by McKesson, it's during one of the worst times of their lives. It's so...

Video Transcript: Risk-Based Care: Personalized care for better outcomes | Dan & Porscha

Risk-Based Care: Personalized care for better outcomes | Dan & Porscha Daniel Weaver, BSN, RN, Director, Clinical Innovation and Strategy, Biologics by McKesson: When patients are referred to Biologics by McKesson, it's during one of the worst times of their...

Video Transcript: Patient Spotlight – Dan W. and Nurse Porscha Scales

Biologics by McKesson Patient Voice Spotlight - Dan W. Yvonne Sims, Senior Manager, Marketing, Biologics by McKesson: So take us to 2021. Describe your health and what ultimately led to your diagnosis. Dan W., Biologics by McKesson Oncology Patient: I noticed that I...

More Insights